Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Infection in Camel Workers in Qatar During 2013–2014: A Case-Control Study

The transmission routes and risk factors for zoonotic Middle East respiratory syndrome coronavirus (MERS-CoV) infections are still unknown. We used the World Health Organization questionnaire for MERS-CoV case-control studies to assess risk factors for human MERS-CoV seropositivity at a farm complex...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 215; no. 11; pp. 1702 - 1705
Main Authors Sikkema, Reina S., Farag, Elmoubasher A. B. A., Himatt, Sayed, Ibrahim, Adel K., Al-Romaihi, Hamad, A. Al-Marri, Salih, Al-Thani, Mohamed, El-Sayed, Ahmed M., Al-Hajri, Mohammed, L. Haagmans, Bart, Koopmans, Marion P. G., Reusken, Chantal B. E. M.
Format Journal Article
LanguageEnglish
Published US Oxford University Press 01.06.2017
Subjects
Adult
Animal Husbandry
Animals
Brief Report
Camelus
Case-Control Studies
Coronavirus Infections - epidemiology
Coronavirus Infections - transmission
Coronavirus Infections - veterinary
Humans
Male
Middle East Respiratory Syndrome Coronavirus
Qatar - epidemiology
Risk Factors
VIRUSES
Zoonoses - epidemiology
Zoonoses - transmission
coronavirus
risk factors
MERS-CoV
transmission
zoonotic
Online AccessGet full text

Cover

More Information
Summary:The transmission routes and risk factors for zoonotic Middle East respiratory syndrome coronavirus (MERS-CoV) infections are still unknown. We used the World Health Organization questionnaire for MERS-CoV case-control studies to assess risk factors for human MERS-CoV seropositivity at a farm complex in Qatar. Nine camel workers with MERS-CoV antibodies and 43 workers without antibodies were included. Some camel-related activities may pose a higher risk of MERS-CoV infection, as may cross-border movements of camels, poor hand hygiene, and overnight hospital stays with respiratory complaints. The risk factors identified in this study can be used to develop infection prevention and control measures for human MERS-CoV infections.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Correspondence: R. Sikkema, MSc, DVM, Department Viroscience, Erasmus Medical Center, Wytemaweg 80, 3015 CN, Rotterdam, the Netherlands (r.sikkema@erasmusmc.nl).
R. S. S. and E. A. B. A. F. contributed equally to this report.
ISSN:0022-1899
1537-6613
DOI:10.1093/infdis/jix174